Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

v3.4.0.3
Notes Payable (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
May. 01, 2015
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Feb. 20, 2015
Debt Instrument [Line Items]            
Number of common stock purchased by issuance of warrants       150,000    
Common stock exercise price   $ 1.00   $ 1.00    
Relative fair value of warrant   $ (1,272,938) $ (138,339) $ (2,161,845) $ (1,642,593)  
Incremental compensation cost       192,147    
Amortization of debt discount   13,516 55,514  
Interest expense, net   $ 26,571 $ 108,783 47,590 $ 154,651  
October 2015 [Member]            
Debt Instrument [Line Items]            
Incremental compensation cost       $ 12,954    
Convertible Notes Payable [Member]            
Debt Instrument [Line Items]            
Convertible note principal amount           $ 200,000
Warrants term       5 years    
Number of common stock purchased by issuance of warrants 50,000     400,000    
Common stock exercise price $ 1.00 $ 1.00   $ 1.00    
Relative fair value of warrant $ 13,516     $ 23,641    
Accrued Interest at the Rate 2.00%          
Debt instrument maturity date Jun. 01, 2015          
Repayment to convertible note payable       100,000    
Converitable Notes Payable One [Member]            
Debt Instrument [Line Items]            
Repayment to convertible note payable       $ 89,937